Medicare Enrolled

Dr. Alejandra Borensztein, MD

Endocrinology · Collingswood, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
900 HADDON AVE # 400-9, Collingswood, NJ 08108
8565597616
In practice since 2009 (17 years)
NPI: 1699909556 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Borensztein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Borensztein? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Borensztein

Dr. Alejandra Borensztein is an endocrinology specialist in Collingswood, NJ, with 17 years of NPI registration. Based on federal Medicare data, Dr. Borensztein performed 457 Medicare services across 262 unique beneficiaries.

Between the years covered by Open Payments, Dr. Borensztein received a total of $3,887 from 40 pharmaceutical and/or device companies across 225 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Borensztein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ 457 Medicare services $3,887 industry payments

Medicare Practice Summary

Medicare Utilization ↗
457
Medicare services
Bottom 26% in NJ for endocrinology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
262
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~27 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
326 $101 $284
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
93 $29 $77
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
23 $123 $366
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
15 $10 $22
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,887
Total received (2019-2024)
Avg $648/year across 6 years
Top 31% in NJ for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
225
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,787 (97.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$100 (2.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$712
2023
$1,815
2022
$1,109
2021
$48
2020
$30
2019
$173

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$176
Novo Nordisk Inc
$164
Lilly USA, LLC
$59
Antares Pharma, Inc.
$41
Verity Pharmaceuticals Inc.
$36
Corcept Therapeutics
$35
Xeris Pharmaceuticals, Inc.
$34
Amgen Inc.
$31
Novartis Pharmaceuticals Corporation
$26
Insulet Corporation
$21
RECORDATI_RARE_DISEASES_INC.
$17
Chiesi USA, Inc.
$16
Amphastar Pharmaceuticals, Inc.
$14
Rhythm Pharmaceuticals, Inc.
$14
Tolmar, Inc.
$14
Radius Health, Inc.
$13
Top 3 companies account for 56.1% of 2024 payments
All-time payments by company (2019-2024) ›
Novo Nordisk Inc
$846
Abbott Laboratories
$608
Lilly USA, LLC
$311
CeQur Corporation
$175
PFIZER INC.
$155
Antares Pharma, Inc.
$143
Insulet Corporation
$134
Xeris Pharmaceuticals, Inc.
$132
Amgen Inc.
$129
Astellas Pharma US Inc
$100
SANOFI-AVENTIS U.S. LLC
$85
Corcept Therapeutics
$85
Ipsen Biopharmaceuticals, Inc
$73
Ascensia Diabetes Care Us Inc.
$69
AstraZeneca Pharmaceuticals LP
$68
Bioventus LLC
$63
Tolmar, Inc.
$59
Medtronic, Inc.
$59
IBSA Pharma Inc.
$58
Intuity Medical Inc
$57
Rhythm Pharmaceuticals, Inc.
$55
Amphastar Pharmaceuticals, Inc.
$48
OPKO Pharmaceuticals, LLC
$42
Verity Pharmaceuticals Inc.
$36
Amryt Pharma Holdings Ltd
$27
Radius Health, Inc.
$27
Novartis Pharmaceuticals Corporation
$26
Bayer Healthcare Pharmaceuticals Inc.
$23
Supernus Pharmaceuticals, Inc.
$19
Ultragenyx Pharmaceutical Inc.
$19
Bayer HealthCare Pharmaceuticals Inc.
$19
Horizon Therapeutics plc
$17
RECORDATI_RARE_DISEASES_INC.
$17
Chiesi USA, Inc.
$16
Tandem Diabetes Care, Inc.
$16
Ascendis Pharma Inc
$16
MannKind Corporation
$14
Alexion Pharmaceuticals, Inc.
$14
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 45.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Aimovig · BAQSIMI · CRYSVITA · CeQur Simplicity · EVENITY · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GELSYN 3 · GVOKE HYPOPEN · IMCIVREE · INPEN SMART INSULIN DELIVERY SYSTEM · Imcivree · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · MINIMED 780G · MOUNJARO · MYCAPSSA · NOCDURNA · Norditropin · Omnipod · Ozempic · PNEUMOVAX 23 · PROCLAIM · Pogo Automatic Blood Glucose Monitoring System · RAYALDEE · Rybelsus · SIGNIFOR LAR · SOMATULINE DEPOT · SOMAVERT · STRENSIQ · Saxenda · Somatuline Depot · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · Tirosint · Tlando · Veozah · Wegovy · XYOSTED · ZEPBOUND · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Collingswood?
Compare endocrinologists in the Collingswood area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
182
Per 100K population
34.7
County median income
$86,384
Nearest hospital
COOPER UNIVERSITY HOSPITAL
3.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Borensztein is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Borensztein experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Borensztein performed 326 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Borensztein receive payments from pharmaceutical companies?
Yes. Dr. Borensztein received a total of $3,887 from 40 companies across 225 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Borensztein's costs compare to other endocrinologists in Collingswood?
Dr. Borensztein's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Borensztein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →